Research programme: oxycodone abuse-resistant - Acura PharmaceuticalsAlternative Names: LTX-01; LTX-02; Oxycodone abuse-resistant - Acura Pharmaceuticals
Latest Information Update: 07 Sep 2016
At a glance
- Originator Acura Pharmaceuticals
- Class Morphine derivatives; Opioid analgesics; Small molecules
- Mechanism of Action Opioid delta receptor agonists; Opioid kappa receptor agonists; Opioid mu receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Pain
Most Recent Events
- 07 Sep 2016 Early research in Pain in USA (PO)